{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:28:07Z","timestamp":1791217687528,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,3,27]],"date-time":"2012-03-27T00:00:00Z","timestamp":1332806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s00223-012-9588-3","type":"journal-article","created":{"date-parts":[[2012,3,26]],"date-time":"2012-03-26T05:21:14Z","timestamp":1332739274000},"page":"439-449","source":"Crossref","is-referenced-by-count":89,"title":["Recent Advances in Osteogenesis Imperfecta"],"prefix":"10.1007","volume":"90","author":[{"given":"Tim","family":"Cundy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,27]]},"reference":[{"key":"9588_CR1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/humu.20429","volume":"28","author":"JC Marini","year":"2007","unstructured":"Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD, Milgrom S, Hyland JC, K\u00f6rkk\u00f6 J, Prockop DJ, De Paepe A, Coucke P, Symoens S, Glorieux FH, Roughley PJ, Lund AM, Kuurila-Svahn K, Hartikka H, Cohn DH, Krakow D, Mottes M, Schwarze U, Chen D, Yang K, Kuslich C, Troendle J, Dalgleish R, Byers PH (2007) Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat 28:209\u2013221","journal-title":"Hum Mutat"},{"key":"9588_CR2","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1242\/jcs.01731","volume":"118","author":"EG Canty","year":"2005","unstructured":"Canty EG, Kadler KE (2005) Procollagen trafficking, processing and fibrillogenesis. J Cell Sci 118:1341\u20131353","journal-title":"J Cell Sci"},{"key":"9588_CR3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00726-008-0073-2","volume":"35","author":"SM Krane","year":"2008","unstructured":"Krane SM (2008) The importance of proline residues in the structure, stability and susceptibility to proteolytic degradations of collagens. Amino Acids 35:703\u2013710","journal-title":"Amino Acids"},{"key":"9588_CR4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","volume":"16","author":"DO Sillence","year":"1979","unstructured":"Sillence DO, Senn A, Danks DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16:101\u2013116","journal-title":"J Med Genet"},{"key":"9588_CR5","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/ajmg.a.33909","volume":"155A","author":"ML Warman","year":"2011","unstructured":"Warman ML, Cormier-Daire V, Hall C, Krakow D, Lachman R, LeMerrer M, Mortier G, Mundlos S, Nishimura G, Rimoin DL, Robertson S, Savarirayan R, Sillence D, Spranger J, Unger S, Zabel B, Superti-Furga A (2011) Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet 155A:943\u2013968","journal-title":"Am J Med Genet"},{"key":"9588_CR6","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1373\/clinchem.2006.083055","volume":"53","author":"T Cundy","year":"2007","unstructured":"Cundy T, Horne A, Bolland M, Gamble G, Davidson J (2007) Bone formation markers in adults with mild osteogenesis imperfecta. Clin Chem 53:1109\u20131114","journal-title":"Clin Chem"},{"key":"9588_CR7","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/ejhg.2009.242","volume":"18","author":"F Rauch","year":"2010","unstructured":"Rauch F, Lalic L, Roughley P, Glorieux FH (2010) Genotype\u2013phenotype correlations in nonlethal osteogenesis imperfecta caused by mutations in the helical domain of collagen type I. Eur J Hum Genet 18:642\u2013647","journal-title":"Eur J Hum Genet"},{"key":"9588_CR8","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1359\/jbmr.091109","volume":"25","author":"F Rauch","year":"2010","unstructured":"Rauch F, Lalic L, Roughley P, Glorieux FH (2010) Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta. J Bone Miner Res 25:1367\u20131374","journal-title":"J Bone Miner Res"},{"key":"9588_CR9","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/ajmg.a.33448","volume":"152","author":"O Semler","year":"2010","unstructured":"Semler O, Cheung MS, Glorieux FH, Rauch F (2010) Wormian bones in osteogenesis imperfecta: correlation to clinical findings and genotype. Am J Med Genet A 152:1681\u20131687","journal-title":"Am J Med Genet A"},{"key":"9588_CR10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/jbmr.220","volume":"26","author":"MS Cheung","year":"2011","unstructured":"Cheung MS, Arponen H, Roughley P, Azouz ME, Glorieux FH, Waltimo-Siren J, Rauch F (2011) Cranial base abnormalities in osteogenesis imperfecta: phenotypic and genotypic determinants. J Bone Miner Res 26:405\u2013413","journal-title":"J Bone Miner Res"},{"key":"9588_CR11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/ajmg.a.32653","volume":"149","author":"E Faqeih","year":"2009","unstructured":"Faqeih E, Roughley P, Glorieux FH, Rauch F (2009) Osteogenesis imperfecta type III with intracranial hemorrhage and brachydactyly associated with mutations in exon 49 of COL1A2. Am J Med Genet A 149:461\u2013465","journal-title":"Am J Med Genet A"},{"key":"9588_CR12","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/humu.21475","volume":"32","author":"K Lindahl","year":"2011","unstructured":"Lindahl K, Barnes AM, Fratzl-Zelman N, Whyte MP, Hefferan TE, Makareeva E, Brusel M, Yaszemski MJ, Rubin CJ, Kindmark A, Roschger P, Klaushofer K, McAlister WH, Mumm S, Leikin S, Kessler E, Boskey AL, Ljunggren O, Marini JC (2011) COL1A1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. Hum Mutat 32:598\u2013609","journal-title":"Hum Mutat"},{"key":"9588_CR13","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1359\/jbmr.2000.15.9.1650","volume":"15","author":"FH Glorieux","year":"2000","unstructured":"Glorieux FH, Rauch F, Plotkin H, Ward L, Travers R, Roughley P, Lalic L, Glorieux DF, Fassier F, Bishop NJ (2000) Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res 15:1650\u20131658","journal-title":"J Bone Miner Res"},{"key":"9588_CR14","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1359\/jbmr.070418","volume":"22","author":"MS Cheung","year":"2007","unstructured":"Cheung MS, Glorieux FH, Rauch F (2007) Natural history of hyperplastic callus formation in osteogenesis imperfecta type V. J Bone Miner Res 22:1181\u20131186","journal-title":"J Bone Miner Res"},{"key":"9588_CR15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2006.08.039","volume":"127","author":"R Morello","year":"2006","unstructured":"Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, Monticone M, Castagnola P, Rauch F, Glorieux FH, Vranka J, Bachinger HP, Pace JM, Schwarze U, Byers PH, Weis M, Fernandes RJ, Eyre DR, Yao Z, Boyce BF, Lee B (2006) CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 127:291\u2013304","journal-title":"Cell"},{"key":"9588_CR16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/ng1968","volume":"39","author":"WA Cabral","year":"2007","unstructured":"Cabral WA, Chang W, Barnes AM, Weis M, Scott MA, Leikin S, Makareeva E, Kuznetsova NV, Rosenbaum KN, Tifft CJ, Bulas DI, Kozma C, Smith PA, Eyre DR, Marini JC (2007) Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal\/severe osteogenesis imperfecta. Nat Genet 39:359\u2013365","journal-title":"Nat Genet"},{"key":"9588_CR17","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/humu.20799","volume":"29","author":"D Baldridge","year":"2008","unstructured":"Baldridge D, Schwarze U, Morello R, Lennington J, Bertin TK, Pace JM, Pepin MG, Weis M, Eyre DR, Walsh J, Lambert D, Green A, Robinson H, Michelson M, Houge G, Lindman C, Martin J, Ward J, Lemyre E, Mitchell JJ, Krakow D, Rimoin DL, Cohn DH, Byers PH, Lee B (2008) CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta. Hum Mutation 29:1435\u20131442","journal-title":"Hum Mutation"},{"key":"9588_CR18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1056\/NEJMoa0907705","volume":"362","author":"AM Barnes","year":"2010","unstructured":"Barnes AM, Carter EM, Cabral WA, Weis M, Chang W, Makareeva E, Leikin S, Rotimi CN, Eyre DR, Raggio CL, Marini JC (2010) Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding. N Engl J Med 362:521\u2013528","journal-title":"N Engl J Med"},{"key":"9588_CR19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ajhg.2010.02.022","volume":"87","author":"Y Alanay","year":"2010","unstructured":"Alanay Y, Avaygan H, Camacho N, Utine GE, Boduroglu K, Aktas D, Alikasifoglu M, Tuncbilek E, Orhan D, Bakar FT, Zabel B, Superti-Furga A, Bruckner-Tuderman L, Curry CJ, Pyott S, Byers PH, Eyre DR, Baldridge D, Lee B, Merrill AE, Davis EC, Cohn DH, Akarsu N, Krakow D (2010) Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. Am J Hum Genet 87:551\u2013559","journal-title":"Am J Hum Genet"},{"key":"9588_CR20","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/jbmr.250","volume":"26","author":"BP Kelley","year":"2011","unstructured":"Kelley BP, Malfait F, Bonafe L, Baldridge D, Homan E, Symoens S, Willaert A, Elcioglu N, Van Maldergem L, Verellen-Dumoulin C, Gillerot Y, Napierala D, Krakow D, Beighton P, Superti-Furga A, De Paepe A, Lee B (2011) Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome. J Bone Miner Res 26:666\u2013672","journal-title":"J Bone Miner Res"},{"key":"9588_CR21","unstructured":"Schwarze U, Cundy T, Pyott S, Christiansen H, Hegde MR, Bank R, Pals G, Ankala A, Connelly K, Seaver L, Yandow S, Raney H, Babovich-Vicsanovic D, Stoler J, Ben-Neriah Z, Segal R, Al-Aqeel A, Siderius L, Hannibal M, Hudgins L, McPherson E, Clemens M, Sussman MD, Steiner R, Mahan J, Smith R, Anyane-Yeboa K, Chong K, Uster T, Aftimos S, Sutton VR, Davis EC, Weis MA, Eyre D, Byers PH (2012) Mutation in FKBP10, which encodes a 65kD FK506 binding prolyl cis-trans isomerase, results in recessive forms of osteogenesis imperfecta and is the first Bruck syndrome (contractures and fractures) locus. Submitted for publication"},{"key":"9588_CR22","doi-asserted-by":"crossref","first-page":"40967","DOI":"10.1074\/jbc.M307380200","volume":"278","author":"AJ Slot Van der","year":"2003","unstructured":"Van der Slot AJ, Zuurmond A-M, Bardoe AFJ, Wijmenga C, Pruijs HEH, Sillence DO, Brinckmann J, Abraham DJ, Black CM, Verzijl N, DeGroot J, Hanemaaijer R, TeKoppele JM, Huizinga TWJ, Bank RA (2003) Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis. J Biol Chem 278:40967\u201340972","journal-title":"J Biol Chem"},{"key":"9588_CR23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ajhg.2010.01.034","volume":"86","author":"HE Christiansen","year":"2010","unstructured":"Christiansen HE, Schwarze U, Pyott SM, AlSwaid A, Al Balwi M, Alrasheed S, Pepin MG, Weis MA, Eyre DR, Byers PH (2010) Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. Am J Hum Genet 86:389\u2013398","journal-title":"Am J Hum Genet"},{"key":"9588_CR24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/humu.21647","volume":"33","author":"V Martinez-Glez","year":"2012","unstructured":"Martinez-Glez V, Valencia M, Caparros-Martin JA, Aglan M, Temtamy S, Tenorio J, Pulido V, Lindert U, Rohrbach M, Eyre D, Giunta C, Lapunzina P, Ruiz-Perez VL (2012) Identification of a mutation causing deficient BMP1\/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta. Hum Mutat 33:343\u2013350","journal-title":"Hum Mutat"},{"key":"9588_CR25","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ajhg.2011.01.015","volume":"88","author":"J Becker","year":"2011","unstructured":"Becker J, Semler O, Gilissen C, Li Y, Bolz HJ, Giunta C, Bergmann C, Rohrbach M, Koerber F, Zimmermann K, de Vries P, Wirth B, Schoenau E, Wollnik B, Veltman JA, Hoischen A, Netzer C (2011) Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am J Hum Genet 88:362\u2013371","journal-title":"Am J Hum Genet"},{"key":"9588_CR26","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1002\/jbmr.487","volume":"26","author":"EP Homan","year":"2011","unstructured":"Homan EP, Rauch F, Grafe I, Lietman C, Doll JA, Dawson B, Bertin T, Napierala D, Morello R, Gibbs R, White L, Miki R, Cohn DH, Crawford S, Travers R, Glorieux FH, Lee B (2011) Mutations in SERPINF1 cause osteogenesis imperfecta type VI. J Bone Miner Res 26:2798\u20132803","journal-title":"J Bone Miner Res"},{"key":"9588_CR27","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","volume":"107","author":"Y Gong","year":"2001","unstructured":"Gong Y, Slee RB, Fukai N, Rawadi G, Roman\u2013Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, Lacombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML (2001) LDL receptor\u2013related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513\u2013523","journal-title":"Cell"},{"key":"9588_CR28","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1086\/497706","volume":"77","author":"M Ai","year":"2005","unstructured":"Ai M, Heeger S, Bartels CF, Schelling DK, Osteoporosis-Pseudoglioma Collaborative Group (2005) Clinical and molecular findings in osteoporosis-pseudoglioma syndrome. Am J Hum Genet 77:741\u2013753","journal-title":"Am J Hum Genet"},{"key":"9588_CR29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajhg.2010.05.016","volume":"87","author":"P Lapunzina","year":"2010","unstructured":"Lapunzina P, Aglan M, Temtamy S, Caparros-Martin JA, Valencia M, Leton R, Martinez-Glez V, Elhossini R, Amr K, Vilaboa N, Ruiz-Perez VL (2010) Identification of a frameshift mutation in osterix in a patient with recessive osteogenesis imperfecta. Am J Hum Genet 87:110\u2013114","journal-title":"Am J Hum Genet"},{"key":"9588_CR30","first-page":"312","volume":"1996","author":"CR Paterson","year":"1996","unstructured":"Paterson CR, Ogston SA, Henry RM (1996) Life expectancy in osteogenesis imperfecta. BMJ 1996:312\u2013351","journal-title":"BMJ"},{"key":"9588_CR31","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJM198406283102602","volume":"310","author":"CR Paterson","year":"1984","unstructured":"Paterson CR, McAllion S, Stellman JL (1984) Osteogenesis imperfecta after the menopause. N Engl J Med 310:1694\u20131696","journal-title":"N Engl J Med"},{"key":"9588_CR32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1258\/0022215011907442","volume":"115","author":"CR Paterson","year":"2001","unstructured":"Paterson CR, Monk EA, McAllion SJ (2001) How common is hearing impairment in osteogenesis imperfecta? J Laryngol Otol 115:280\u2013282","journal-title":"J Laryngol Otol"},{"key":"9588_CR33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1540-8175.2009.00973.x","volume":"27","author":"RE Bonita","year":"2010","unstructured":"Bonita RE, Cohen IS, Berko BA (2010) Valvular heart disease in osteogenesis imperfecta: presentation of a case and review of the literature. Echocardiography 27:69\u201373","journal-title":"Echocardiography"},{"key":"9588_CR34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1359\/jbmr.2003.18.1.126","volume":"18","author":"S Adami","year":"2003","unstructured":"Adami S, Gatti D, Colapietro F, Fracassi E, Braga V, Rossini M, Tato L (2003) Intravenous neridronate in adults with osteogenesis imperfecta. J Bone Miner Res 18:126\u2013130","journal-title":"J Bone Miner Res"},{"key":"9588_CR35","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1359\/JBMR.051015","volume":"21","author":"G Chevrel","year":"2006","unstructured":"Chevrel G, Schott A-M, Fontanges E, Charrin JE, Lina-Granade G, Duboeuf F, Garnero P, Arlot M, Raynal C, Meunier PJ (2006) Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trial. J Bone Miner Res 21:300\u2013306","journal-title":"J Bone Miner Res"},{"key":"9588_CR36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00198-011-1658-2","volume":"23","author":"LA Bradbury","year":"2012","unstructured":"Bradbury LA, Barlow S, Geoghegan F, Hannon RA, Stuckey SL, Wass JAH, Russell RGG, Brown MA, Duncan EL (2012) Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists. Osteoporos Int 23:285\u2013294","journal-title":"Osteoporos Int"},{"key":"9588_CR37","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF00350961","volume":"16","author":"JP Devogelaer","year":"1987","unstructured":"Devogelaer JP, Malghem J, Maldague B, Nagant de Deuxchaines C (1987) Radiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfecta. Skel Radiol 16:360\u2013363","journal-title":"Skel Radiol"},{"key":"9588_CR38","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","volume":"363","author":"F Rauch","year":"2004","unstructured":"Rauch F, Glorieux FH (2004) Osteogenesis imperfecta. Lancet 363:1377\u20131385","journal-title":"Lancet"},{"key":"9588_CR39","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/jbmr.180","volume":"26","author":"S Gamsjaeger","year":"2011","unstructured":"Gamsjaeger S, Buchinger B, Zwettler E, Recker R, Black D, Gasser JA, Eriksen EF, Klaushofer K, Paschalis EP (2011) Bone material properties in actively bone-forming trabeculae in postmenopausal women with osteoporosis after three years of treatment with once-yearly zoledronic acid. J Bone Miner Res 26:12\u201318","journal-title":"J Bone Miner Res"},{"key":"9588_CR40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00223-008-9113-x","volume":"82","author":"P Roschger","year":"2008","unstructured":"Roschger P, Fratzl-Zelman N, Misof BM, Glorieux FH, Klaushofer K, Rauch F (2008) Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutations. Calcif Tissue Int 82:263\u2013270","journal-title":"Calcif Tissue Int"},{"key":"9588_CR41","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1359\/JBMR.051207","volume":"21","author":"C Land","year":"2006","unstructured":"Land C, Rauch F, Glorieux FH (2006) Cyclical intravenous pamidronate treatment affects metaphyseal modeling in growing patients with osteogenesis imperfecta. J Bone Miner Res 21:374\u2013379","journal-title":"J Bone Miner Res"},{"key":"9588_CR42","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1359\/JBMR.040814","volume":"19","author":"CF Munns","year":"2004","unstructured":"Munns CF, Rauch F, Zeitlin L, Fassier F, Glorieux FH (2004) Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate. J Bone Miner Res 19:1779\u20131786","journal-title":"J Bone Miner Res"},{"key":"9588_CR43","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1359\/jbmr.090213","volume":"24","author":"F Rauch","year":"2009","unstructured":"Rauch F, Munns CF, Land C, Cheung M, Glorieux FH (2009) Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study. J Bone Miner Res 24:1282\u20131289","journal-title":"J Bone Miner Res"},{"key":"9588_CR44","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1210\/jc.2010-0636","volume":"96","author":"LM Ward","year":"2011","unstructured":"Ward LM, Rauch F, Whyte MP, D\u2019Astous J, Gates PE, Grogan D, Lester EL, McCall RE, Pressly TA, Sanders JO, Smith PA, Steiner RD, Sullivan E, Tyerman G, Smith-Wright DL, Verbruggen N, Heyden N, Lombardi A, Glorieux FH (2011) Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study. J Clin Endocrinol Metab 96:355\u2013364","journal-title":"J Clin Endocrinol Metab"},{"key":"9588_CR45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1359\/jbmr.090712","volume":"25","author":"N Bishop","year":"2010","unstructured":"Bishop N, Harrison R, Ahmed F, Shaw N, Eastell R, Campbell M, Knowles E, Hill C, Hall C, Chapman S, Sprigg A, Rigby A (2010) A randomized, controlled dose-ranging study of risedronate in children with moderate and severe osteogenesis imperfecta. J Bone Miner Res 25:32\u201340","journal-title":"J Bone Miner Res"},{"key":"9588_CR46","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1530\/EJE-10-0208","volume":"163","author":"F Antoniazzi","year":"2010","unstructured":"Antoniazzi F, Monti E, Venturi G, Franceschi R, Doro F, Gatti D, Zamboni G, Tato L (2010) Growth hormone in combination with bisphosphonate treatment in osteogenesis imperfecta. Eur J Endocrinol 163:479\u2013487","journal-title":"Eur J Endocrinol"},{"key":"9588_CR47","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bone.2006.11.020","volume":"40","author":"F Rauch","year":"2007","unstructured":"Rauch F, Cornibert S, Cheung M, Glorieux FH (2007) Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta. Bone 40:821\u2013827","journal-title":"Bone"},{"key":"9588_CR48","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1359\/jbmr.081225","volume":"24","author":"MS Cheung","year":"2009","unstructured":"Cheung MS, Glorieux FH, Rauch F (2009) Large osteoclasts in pediatric osteogenesis imperfecta patients receiving intravenous pamidronate. J Bone Miner Res 24:669\u2013674","journal-title":"J Bone Miner Res"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-012-9588-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-012-9588-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-012-9588-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T03:41:18Z","timestamp":1713757278000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-012-9588-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,27]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["9588"],"URL":"https:\/\/doi.org\/10.1007\/s00223-012-9588-3","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,27]]}}}